QA: Arcutis Biotherapeutics Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001787306_2025_Arcutis_Biotherapeutics_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001787306, Arcutis Biotherapeutics Inc

  xvar xval
0 AssetsCurrent 335,820,000
1 IntangibleAssetsNetIncludingGoodwill 9,479,000
2 PropertyPlantAndEquipmentNet 1,041,000
3 remainder_Assets 2,549,000
4 LiabilitiesCurrent 81,013,000
5 LiabilitiesNoncurrent 110,335,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 89,790,736
8 SellingGeneralAndAdministrativeExpense 450,176,718
9 ResearchAndDevelopmentExpense 67,202,391
10 remainder_Expenses 28,401,699
11 remainder_Revenues 880,938,246
12 remainder_NetIncome 15,439,149
13 remainder_ComprehensiveNetIncome 576,814
  yvar yval
0 Assets 348,889,000
1 Liabilities 191,348,000
2 Expenses 635,571,544
3 Revenues 880,938,246
4 StockholdersEquity 157,541,000
5 NetIncome 260,805,851
6 ComprehensiveNetIncome 261,094,258
7 BaseVar 1,036,381,376
8 EconomicCapitalRatiobeforeLimitedLiability 2.24
9 EconomicCapitalRatio 3.18

Edgar->Model Mapping

Feature Distribution

Change over Time